Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Carcinogenesis

• Publication date

  2008-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.20362PMID 17683065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MEROPS: the peptidase database

  2009cited by this paper
• The etiology of osteosarcoma.

  2009cited by this paper
• High WT1 Expression Is Associated with Very Poor Survival of Patients with Osteogenic Sarcoma Metastasis

  2006cited by this paper
• Human osteoblasts produce cathepsin K.

  2006cited by this paper
• Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.

  2006cited by this paper
• Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.

  2006cited by this paper
• Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.

  2006cited by this paper
• Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis.

  2006cited by this paper
• Cysteine cathepsins: multifunctional enzymes in cancer

  2006cited by this paper
• Catalytically inactive human cathepsin D triggers fibroblast invasive growth

  2005influential reference
• Lysosomes as targets for cancer therapy.

  2005influential reference
• Proteases and metastasis: clinical relevance nowadays?

  2005cited by this paper
• Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

  2005cited by this paper
• MEROPS: the peptidase database

  2005cited by this paper
• Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer

  2005cited by this paper
• Expression of cathepsins B, H, and L and their inhibitors as markers of transitional cell carcinoma of the bladder.

  2004cited by this paper
• Cathepsin K is the principal protease in giant cell tumor of bone.

  2004cited by this paper
• Modeling metastasis in vivo.

  2004cited by this paper
• Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer.

  2004cited by this paper
• Biology and therapeutic advances for pediatric osteosarcoma.

  2004cited by this paper
• Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L

  2004cited by this paper
• Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma

  2004cited by this paper
• Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma Cells

  2004cited by this paper
• A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies

  2004cited by this paper
• Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma.

  2003cited by this paper
• The basement membrane matrix in malignancy

  2003cited by this paper
• Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression

  2003cited by this paper
• Etiology of osteosarcoma.

  2002cited by this paper
• Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer.

  2002cited by this paper
• Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.

  2002cited by this paper
• Discordant Protein and mRNA Expression in Lung Adenocarcinomas *

  2002cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001cited by this paper
• Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma

  2001cited by this paper
• Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotype

  2001cited by this paper
• Invasion of ras-Transformed Breast Epithelial Cells Depends on the Proteolytic Activity of Cysteine and Aspartic Proteinases

  2001cited by this paper
• Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases.

  2000cited by this paper
• Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer.

  2000cited by this paper
• Protease expression in dedifferentiated parosteal osteosarcoma.

  1999cited by this paper
• Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.

  1999cited by this paper
• Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur.

  1998cited by this paper
• Enhanced expression of cathepsin L in metastatic bone tumors.

  1996cited by this paper
• Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P-450, and calbindin D28k in human kidney.

  1994cited by this paper
• Expression of cathepsin L in human tumors.

  1991cited by this paper
• Identification of latent procathepsin H in microsomal lumen: characterization of proteolytic processing and enzyme activation.

  1988cited by this paper

• Simultaneous detection of multiple cathepsin activities by peptide microarray-based metal-enhanced fluorescence assay

  2026cites this paper
• Development and Application of Small Molecule–Peptide Conjugates as Cathepsin K-Specific Covalent Irreversible Inhibitors in Human Osteoclast and Lung Cancer

  2025cites this paper
• Ugonin inhibits chondrosarcoma metastasis through suppressing cathepsin V via promoting miR-4799-5p expression

  2025cites this paper
• Cysteine Cathepsins: From Diagnosis to Targeted Therapy of Cancer.

  2024cites this paper
• Development and Application of Reversible and Irreversible Covalent Probes for Human and Mouse Cathepsin‐K Activity Detection, Revealing Nuclear Activity

  2024cites this paper
• Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design

  2024cites this paper
• The intersection between cysteine proteases, Ca2+ signalling and cancer cell apoptosis.

  2023cites this paper
• ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.

  2022cites this paper
• Highly potent inhibitors of cathepsin K with a differently positioned cyanohydrazide warhead: structural analysis of binding mode to mature and zymogen-like enzymes

  2022cites this paper
• Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives

  2022cites this paper
• Cathepsin Protease Expression in Infiltrative Soft Tissue Sarcomas: Cathepsin-K Correlates with Infiltrative Tumor Growth and Clinical Outcome.

  2022cites this paper
• Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction

  2022cites this paper
• An Activity-Based Probe for Cathepsin K Imaging with Excellent Potency and Selectivity.

  2021cites this paper
• Role of lysosomes in physiological activities, diseases, and therapy

  2021cites this paper
• Nanotechnology in Skin, Soft Tissue, and Bone Infections

  2020cites this paper
• Cathepsin K and Its Specific Target in Mediating Breast Cancer Skeletal Metastasis

  2020cites this paper
• The Role of Cathepsins in the Growth of Primary and Secondary Neoplasia in the Bone

  2020influential citation
• The Potential Role of Cathepsin K in Non-Small Cell Lung Cancer

  2020cites this paper
• The Bone Biology and the Nanotechnology for Bone Engineering and Bone Diseases

  2020cites this paper
• Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis

  2020cites this paper
• Characterization and initial functional analysis of cathepsin K in turbot (Scophthalmus maximus L.).

  2019cites this paper
• Cysteine cathepsins as a prospective target for anticancer therapies-current progress and prospects.

  2018cites this paper
• Elevated Cathepsin K potentiates metastasis of epithelial ovarian cancer.

  2018cites this paper
• Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K.

  2018cites this paper
• Bone-Targeted Therapies in Cancer-Induced Bone Disease

  2018cites this paper
• Physiological and Pathological Functions of Cysteine Cathepsins

  2017cites this paper
• Double Sequential Encrypted Targeting Sequence: A New Concept for Bone Cancer Treatment.

  2017cites this paper
• Expression of Cathepsin K in Skull Base Chordoma.

  2017cites this paper
• Proteases in Physiology and Pathology

  2017cites this paper
• MiRNA-7 targets cathepsin K to inhibit invasion and metastasis of neuroblastoma cells

  2017cites this paper
• The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease

  2017cites this paper
• Identification and Validation of DLG2 as a Novel Tumor Suppressor in Osteosarcoma

  2016cites this paper
• Photoactivated inhibition of cathepsin K in a 3D tumor model

  2016cites this paper
• Endo180 at the cutting edge of bone cancer treatment and beyond†

  2016cites this paper
• The role of Cathepsin K in haematopoiesis

  2016cites this paper
• Identification of novel cathepsin K inhibitors using ligand-based virtual screening and structure-based docking

  2016cites this paper
• Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk

  2015cites this paper
• Genomic Instability of Osteosarcoma Cell Lines in Culture: Impact on the Prediction of Metastasis Relevant Genes

  2015cites this paper
• Signal transduction and downregulation of C-MET in HGF stimulated low and highly metastatic human osteosarcoma cells.

  2015cites this paper
• Cathepsin L targeting in cancer treatment.

  2015cites this paper
• Complexity of cancer protease biology: Cathepsin K expression and function in cancer progression.

  2015cites this paper
• Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response

  2015cites this paper
• Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies

  2015cites this paper
• Carbon-11 labeled cathepsin K inhibitors: syntheses and preliminary in vivo evaluation.

  2014cites this paper
• Expression of the Chemokine Receptor CXCR7 in CXCR4-Expressing Human 143B Osteosarcoma Cells Enhances Lung Metastasis of Intratibial Xenografts in SCID Mice

  2013cites this paper
• Papain-like peptidases: structure, function, and evolution

  2013cites this paper
• Cathepsin K: a unique collagenolytic cysteine peptidase

  2013cites this paper
• Matrix Metalloproteinase 1 promotes tumor formation and lung metastasis in an intratibial injection osteosarcoma mouse model.

  2013cites this paper
• The role of cathepsins in osteoimmunology.

  2013cites this paper
• In vitro anti-cancer effects of benzimidazoles on the canine osteosarcoma D17 cell line

  2013cites this paper
• Proteases in Cancer: Significance for Invasion and Metastasis

  2013cites this paper
• Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line Systems

  2012cites this paper
• Histopathology and Molecular Pathology of Bone and Extraskeletal Osteosarcomas

  2012cites this paper
• Cathepsin K expression and activity in canine osteosarcoma.

  2012cites this paper
• Diagnostic and Prognostic Sarcoma Signatures

  2012cites this paper
• Overexpression of Cathepsin Z Contributes to Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

  2011cites this paper
• Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances.

  2011influential citation
• Involvement of angiotensin II type 1 receptors in interleukin-1β-induced interleukin-6 production in human gingival fibroblasts.

  2011cites this paper
• Cathepsin K-upregulation in fibroblasts promotes matrigel invasive ability of squamous cell carcinoma cells via tumor-derived IL-1α.

  2011cites this paper
• Cathepsin L in Normal and Pathological Bone Remodeling

  2011influential citation
• The Molecular Pathogenesis of Osteosarcoma: A Review

  2011cites this paper
• Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma.

  2010cites this paper
• Clinical and functional outcomes of patients with a pathologic fracture in high‐grade osteosarcoma

  2010cites this paper
• Proteases and Therapeutic Approaches of Bone Tumors

  2010cites this paper
• Cathepsin L in metastatic bone disease: therapeutic implications

  2010influential citation
• Overexpression of stromal cathepsin K expression correlates with invasiveness of extramammary Paget's disease.

  2010cites this paper
• Molecular and cellular mechanisms of osteosarcoma metastasis: current knowledge and perspectives

  2009cites this paper
• [Proteases in cancer progression].

  2009cites this paper
• Proteases and bone remodelling.

  2009cites this paper
• Preferential expression of the secreted and membrane forms of tumor endothelial marker 7 transcripts in osteosarcoma.

  2009cites this paper
• Condicionantes epidemiológicos de salud y su relación con rendimiento escolar en el primer año de la carrera de medicina

  2009cites this paper
• Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics

  2009cites this paper
• Hochauflösende Charakterisierung von DNA-Amplifikationen im Pankreaskarziom

  2009cites this paper
• Las proteasas en la progresión neoplásica

  2009cites this paper
• Diagnostic and prognostic sarcoma signatures.

  2008cites this paper
• Metastatic Osteosarcoma Gene Expression Differs In Vitro and In Vivo

  2008cites this paper